期刊
EXPERT REVIEW OF HEMATOLOGY
卷 3, 期 3, 页码 273-283出版社
TAYLOR & FRANCIS LTD
DOI: 10.1586/EHM.10.24
关键词
cord blood transplantation; CXCR4; engraftment; ex vivo expansion; hematopoietic stem cell; Notch; SDF-1; stem cell homing; umbilical cord blood
类别
资金
- NIH [5RC1HL099447-02]
Umbilical cord blood (UCB) has been used successfully as a source of hematopoietic stem cells (HSCs) for allogeneic transplantation in children and adults in the treatment of hematologic diseases. However, compared with marrow or mobilized peripheral blood stem cell grafts from adult donors, significant delays in the rates and kinetics of neutrophil and platelet engraftment are noted after UCB transplant. These differences relate in part to the reduced numbers of HSCs in UCB grafts. To improve the rates and kinetics of engraftment of UCB HSC, several strategies have been proposed, including ex vivo expansion of UCB HSCs, addition of third-party mesenchymal cells, intrabone delivery of HSCs, modulation of CD26 expression, and infusion of two UCB grafts. This article will focus on ex vivo expansion of UCB HSCs and strategies to enhance UCB homing as potential solutions to overcome the problem of low stem cell numbers in a UCB graft.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据